News
Fintel on MSN3d
Cantor Fitzgerald Initiates Coverage of Trevi Therapeutics (TRVI) with Overweight RecommendationFintel reports that on July 1, 2025, Cantor Fitzgerald initiated coverage of Trevi Therapeutics (NasdaqGM:TRVI) with a ...
Haduvio met the primary endpoint with statistically-significant reductions in 24-hour cough frequency across all dose groups (108 and 54 mg BID p<0.0001; 27 mg BID p<0.01); a -43.3% placebo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback